168 related articles for article (PubMed ID: 1314113)
1. Epstein-Barr viral DNA in acute large granular lymphocyte (natural killer) leukemic cells.
Hart DN; Baker BW; Inglis MJ; Nimmo JC; Starling GC; Deacon E; Rowe M; Beard ME
Blood; 1992 Apr; 79(8):2116-23. PubMed ID: 1314113
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a novel human natural killer-cell line (NK-YS) established from natural killer cell lymphoma/leukemia associated with Epstein-Barr virus infection.
Tsuchiyama J; Yoshino T; Mori M; Kondoh E; Oka T; Akagi T; Hiraki A; Nakayama H; Shibuya A; Ma Y; Kawabata T; Okada S; Harada M
Blood; 1998 Aug; 92(4):1374-83. PubMed ID: 9694726
[TBL] [Abstract][Full Text] [Related]
3. Failure to detect Epstein-Barr virus DNA in peripheral blood mononuclear cells of most patients with large granular lymphocyte leukemia.
Loughran TP; Zambello R; Ashley R; Guderian J; Pellenz M; Semenzato G; Starkebaum G
Blood; 1993 May; 81(10):2723-7. PubMed ID: 8387836
[TBL] [Abstract][Full Text] [Related]
4. Detection of Epstein-Barr virus genome in natural-killer-like cell line, YT.
Yoneda N; Tatsumi E; Kawano S; Teshigawara K; Oka T; Fukuda M; Yamaguchi N
Leukemia; 1992 Feb; 6(2):136-41. PubMed ID: 1313126
[TBL] [Abstract][Full Text] [Related]
5. CD3+, CD56+ aggressive variant of large granular lymphocyte leukemia.
Gentile TC; Uner AH; Hutchison RE; Wright J; Ben-Ezra J; Russell EC; Loughran TP
Blood; 1994 Oct; 84(7):2315-21. PubMed ID: 7522625
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus DNA and latent gene products in Ki-1 (CD30)-positive anaplastic large cell lymphomas.
Herbst H; Dallenbach F; Hummel M; Niedobitek G; Finn T; Young LS; Rowe M; Müller-Lantzsch N; Stein H
Blood; 1991 Nov; 78(10):2666-73. PubMed ID: 1668608
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus-associated natural killer-large granular lymphocyte leukemia.
Gelb AB; van de Rijn M; Regula DP; Cornbleet JP; Kamel OW; Horoupian DS; Cleary ML; Warnke RA
Hum Pathol; 1994 Sep; 25(9):953-60. PubMed ID: 8088773
[TBL] [Abstract][Full Text] [Related]
8. Establishment and characterization of the T-cell line, EBT-8 latently infected with Epstein-Barr virus from large granular lymphocyte leukemia.
Asada H; Okada N; Hashimoto K; Yamanishi K; Sairenji T; Hirota S; Nomura S; Kitamura Y; Yoshikawa K
Leukemia; 1994 Aug; 8(8):1415-23. PubMed ID: 8057683
[TBL] [Abstract][Full Text] [Related]
9. Interleukin 15-mediated induction of cytotoxic effector cells capable of eliminating Epstein-Barr virus-transformed/immortalized lymphocytes in culture.
Sharif-Askari E; Fawaz LM; Tran P; Ahmad A; Menezes J
J Natl Cancer Inst; 2001 Nov; 93(22):1724-32. PubMed ID: 11717333
[TBL] [Abstract][Full Text] [Related]
10. The latency pattern of Epstein-Barr virus infection and viral IL-10 expression in cutaneous natural killer/T-cell lymphomas.
Xu ZG; Iwatsuki K; Oyama N; Ohtsuka M; Satoh M; Kikuchi S; Akiba H; Kaneko F
Br J Cancer; 2001 Apr; 84(7):920-5. PubMed ID: 11286472
[TBL] [Abstract][Full Text] [Related]
11. Lack of the expression of EBNA-2 and LMP-1 in T-cell neoplasms possessing Epstein-Barr virus.
Suzushima H; Asou N; Fujimoto T; Nishimura S; Okubo T; Yamasaki H; Osato M; Matsuoka M; Tsukamoto A; Takai K
Blood; 1995 Jan; 85(2):480-6. PubMed ID: 7812002
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus (EBV)-induced CD30+ natural killer cell-type malignancy resembling malignant histiocytosis: malignant transformation in chronic active EBV infection associating hypogammaglobulinemia.
Tsutsumi Y; Tang X; Yamada T
Pathol Int; 1997 Jun; 47(6):384-92. PubMed ID: 9211526
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus is localized in the tumour cells of nasal lymphomas of NK, T or B cell type.
Tao Q; Ho FC; Loke SL; Srivastava G
Int J Cancer; 1995 Jan; 60(3):315-20. PubMed ID: 7829236
[TBL] [Abstract][Full Text] [Related]
14. Aggressive variant of morphologically typical T large granular lymphocyte leukemia/lymphoma lacking NK cell markers.
Passetto Falcão R; Pinto Simões B; Garcia AB; Fonseca BA; Terra Filho J
Acta Haematol; 2000; 104(2-3):110-4. PubMed ID: 11154985
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus infection and associated products (LMP, EBNA2, vIL-10) in nodal non-Hodgkin's lymphoma of human immunodeficiency virus-negative Japanese.
Ohshima K; Suzumiya J; Tasiro K; Mukai Y; Tanaka T; Kato A; Kikuchi M
Am J Hematol; 1996 May; 52(1):21-8. PubMed ID: 8638607
[TBL] [Abstract][Full Text] [Related]
16. Nasal T/natural killer (NK)-cell lymphomas are derived from Epstein-Barr virus-infected cytotoxic lymphocytes of both NK- and T-cell lineage.
Chiang AK; Chan AC; Srivastava G; Ho FC
Int J Cancer; 1997 Nov; 73(3):332-8. PubMed ID: 9359478
[TBL] [Abstract][Full Text] [Related]
17. Nasal T-cell lymphoma: a clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus.
Kanavaros P; Lescs MC; Brière J; Divine M; Galateau F; Joab I; Bosq J; Farcet JP; Reyes F; Gaulard P
Blood; 1993 May; 81(10):2688-95. PubMed ID: 8387835
[TBL] [Abstract][Full Text] [Related]
18. Polymorphism analysis of Epstein-Barr virus isolates from patients with cutaneous natural killer/T-cell lymphoproliferative disorders: A possible relation to the endemic occurrence of these diseases in Japan.
Xu ZG; Iwatsuki K; Ohtsuka M; Oyama N; Matsui T; Kaneko F
J Med Virol; 2000 Oct; 62(2):239-46. PubMed ID: 11002254
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23.
Wang F; Gregory C; Sample C; Rowe M; Liebowitz D; Murray R; Rickinson A; Kieff E
J Virol; 1990 May; 64(5):2309-18. PubMed ID: 2157887
[TBL] [Abstract][Full Text] [Related]
20. Genotypic and phenotypic alterations in Epstein-Barr virus-associated lymphoma.
Ohshima K; Suzumiya J; Kanda M; Haraoka S; Kawasaki C; Shimazaki K; Kikuchi M
Histopathology; 1999 Dec; 35(6):539-50. PubMed ID: 10583578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
